Clinical Study

Effect of Spirulina Intervention on Oxidative Stress, Antioxidant Status, and Lipid Profile in Chronic Obstructive Pulmonary Disease Patients

Table 4

Effect of spirulina intervention at (500 × 2) mg dose on serum content of oxidants and antioxidants and on the activity of burst enzymes in COPD patients.

Parameters 0 days
(mean ± SD)
30 days
(mean ± SD)
60 days
(mean ± SD)
value value

Malondialdehyde (MDA) (nmoL/mL)3.78 ± 0.243.32 ± 0.26 2.99 ± 0.22 85.083 0.000*
Lipid hydroperoxide (nmoL/mL)3.63 ± 0.19 3.41 ± 0.212.79 ± 0.22 136.057 0.000*
Catalase (kU/L)31.53 ± 8.4133.33 ± 8.3034.05 ± 8.08 0.740 0.480
Superoxide dismutase (SOD) (U/mL)67.25 ± 6.4370.64 ± 6.2075.89 ± 5.34 15.742 0.000*
Glutathione-S-transferase (GST) (U/mL)28.41 ± 4.0229.14 ± 4.0530.95 ± 3.50 3.408 0.038*
Glutathione (GSH) (nmoL/mL)279.3 ± 23.26302.28 ± 18.42332.61 ± 13.61 60.399 0.000*
Vitamin C (mg/dL)0.76 ± 0.070.83 ± 0.060.92 ± 0.05 52.971 0.000*
Cholesterol (mg/dL)167.22 ± 10.33162.15 ± 9.03152.08 ± 7.95 21.233 0.000*
Triglyceride (TG) (mg/dL)172.10 ± 14.44169.55 ± 14.15167.18 ± 12.22 0.975 0.381
High density lipoprotein (HDL) (mg/dL)42.21 ± 5.1742.72 ± 5.1243.45 ± 5.20 0.436 0.648

Statistically significant. Comparisons are made between day 0 versus day 30 and day 0 versus day 60.